相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics
Bhuvaneshwar Vaidya et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer
Snehal K. Shukla et al.
PHARMACEUTICAL RESEARCH (2020)
D-alpha-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming
Xi Tan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Dual-Ligand Modification of PEGylated Liposomes Used for Targeted Doxorubicin Delivery to Enhance Anticancer Efficacy
Cong Li et al.
AAPS PHARMSCITECH (2019)
Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model
Juliana de Oliveira Silva et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Brain-targeted drug delivery by manipulating protein corona functions
Zui Zhang et al.
NATURE COMMUNICATIONS (2019)
Double-Edged Lipid Nanoparticles Combining Liposome-Bound TRAIL and Encapsulated Doxorubicin Showing an Extraordinary Synergistic Pro-Apoptotic Potential
Diego De Miguel et al.
CANCERS (2019)
Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma
Xuelei Yin et al.
DRUG DELIVERY (2018)
Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity
Xiao-qian Dou et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance
Fateme Haghiralsadat et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicines
Nian-Qiu Shi et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy
Xue-jia Kang et al.
ACTA PHARMACOLOGICA SINICA (2017)
Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma
Mingqing Yuan et al.
DRUG DELIVERY (2016)
Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model
Seyedeh Alia Moosavian et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Evaluation of the antitumor effect of dexamethasone palmitate and doxorubicin co-loaded liposomes modified with a sialic acid-octadecylamine conjugate
Jing Sun et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid
Shravan Kumar Sriraman et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
HER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery
Lingling Geng et al.
THERANOSTICS (2016)
Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma
Hea Ry Oh et al.
NANOMATERIALS (2016)
Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity
Jie Tang et al.
DRUG DELIVERY (2016)
Design of liposomal formulations for cell targeting
Eugenia Nogueira et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers
Cedar H. A. Boalwe et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach
Vivek Makwana et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Targeted delivery of doxorubicin to breast cancer cells by aptamer functionalized DOTAP/DOPE liposomes
Xingli Song et al.
ONCOLOGY REPORTS (2015)
Enhanced Specificity and Drug Delivery in Tumors by cRGD - Anchoring Thermosensitive Liposomes
Bilyana M. Dicheva et al.
PHARMACEUTICAL RESEARCH (2015)
Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models
Anjali Apte et al.
CANCER BIOLOGY & THERAPY (2014)
Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer
Timothy M. Zagar et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2014)
GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation
Liang Cheng et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
An overview of doxorubicin formulations in cancer therapy
Sangeeta Rivankar
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2014)
Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes
Eric E. Paoli et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)
Pieter J. Gaillard et al.
PLOS ONE (2014)
Folate and TAT Peptide Co-Modified Liposomes Exhibit Receptor-Dependent Highly Efficient Intracellular Transport of Payload In Vitro and In Vivo
Yaqin Zhu et al.
PHARMACEUTICAL RESEARCH (2014)
Targeted and and ultrasound-triggered drug delivery using liposomes co-modified with cancer cell-targeting aptamers and a thermosensitive polymer
Kazuaki Ninomiya et al.
ULTRASONICS SONOCHEMISTRY (2014)
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
Kanika Madaan et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2014)
From Phage Display to Nanoparticle Delivery: Functionalizing Liposomes with Multivalent Peptides Improves Targeting to a Cancer Biomarker
Bethany Powell Gray et al.
BIOCONJUGATE CHEMISTRY (2013)
Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphoma
Ommoleila Molavi et al.
BIOMATERIALS (2013)
Octa-arginine-modified pegylated liposomal doxorubicin: An effective treatment strategy for non-small cell lung cancer
Swati Biswas et al.
CANCER LETTERS (2013)
Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity
Swati Biswas et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Liposomes Decorated with Apo2L/TRAIL Overcome Chemoresistance of Human Hematologic Tumor Cells
Diego De Miguel et al.
MOLECULAR PHARMACEUTICS (2013)
Thrombin-Targeted Liposomes Establish a Sustained Localized Anticlotting Barrier against Acute Thrombosis
Rohun U. Palekar et al.
MOLECULAR PHARMACEUTICS (2013)
Tumor-penetrating peptide functionalization enhances the anti-glioblastoma effect of doxorubicin liposomes
Yiyi Yang et al.
NANOTECHNOLOGY (2013)
Enhanced Active Targeting via Cooperative Binding of Ligands on Liposomes to Target Receptors
Tomoki Sugiyama et al.
PLOS ONE (2013)
Local Targeted Therapy of Liver Metastasis from Colon Cancer by Galactosylated Liposome Encapsulated with Doxorubicin
Chen Zhao et al.
PLOS ONE (2013)
Selective delivery of an anticancer drug with aptamer-functionalized liposomes to breast cancer cells in vitro and in vivo
Hang Xing et al.
JOURNAL OF MATERIALS CHEMISTRY B (2013)
Nanoparticle Delivery of Cancer Drugs
Andrew Z. Wang et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Elastin-like polypeptide modified liposomes for enhancing cellular uptake into tumor cells
Kyunga Na et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2012)
Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats
Zhongya Chen et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes
Sarandeep Singh Malhi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Polymeric micelles drug delivery system in oncology
Jian Gong et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity
Erez Koren et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Estrogen-Anchored pH-Sensitive Liposomes as Nanomodule Designed for Site-Specific Delivery of Doxorubicin in Breast Cancer Therapy
Shivani R. Paliwal et al.
MOLECULAR PHARMACEUTICS (2012)
Application of Collagen-Model Triple-Helical Peptide-Amphiphiles for CD44-Targeted Drug Delivery Systems
Margaret W. Ndinguri et al.
JOURNAL OF DRUG DELIVERY (2012)
Preparation, Characterization and Applications of Liposomes: State of the Art
A. Laouini et al.
JOURNAL OF COLLOID SCIENCE AND BIOTECHNOLOGY (2012)
EphA2 Targeted Doxorubicin Stealth Liposomes as a Therapy System for Choroidal Neovascularization in Rats
Jia-lin Wang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Development and Characterization of Doxorubicin Bearing Vitamin B12 Coupled Sterically Stabilized Liposomes for Tumor Targeting
Yashwant Gupta et al.
CURRENT NANOSCIENCE (2011)
Cell-penetrating TAT peptide in drug delivery systems: Proteolytic stability requirements
Erez Koren et al.
DRUG DELIVERY (2011)
A phase I study of doxorubicin-loaded anti-EGFR immunoliposomes in patients with advanced solid tumors.
C. Mamot et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Antibody derivatization and conjugation strategies: Application in preparation of stealth immunoliposome to target chemotherapeutics to tumor
Arehalli S. Manjappa et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Reduction-Sensitive Liposomes from a Multifunctional Lipid Conjugate and Natural Phospholipids: Reduction and Release Kinetics and Cellular Uptake
Bjoern Goldenbogen et al.
LANGMUIR (2011)
Heterogeneous Liposome Membranes with pH-Triggered Permeability Enhance the in Vitro Antitumor Activity of Folate-Receptor Targeted Liposomal Doxorubicin
Elina Marnasheva et al.
MOLECULAR PHARMACEUTICS (2011)
Liposome-Bound APO2L/TRAIL Is an Effective Treatment in a Rabbit Model of Rheumatoid Arthritis
Luis Martinez-Lostao et al.
ARTHRITIS AND RHEUMATISM (2010)
In vivo targeting of B-cell lymphoma with glycan ligands of CD22
Weihsu C. Chen et al.
BLOOD (2010)
A novel DDS strategy, dual-targeting, and its application for antineovascular therapy
Yuki Murase et al.
CANCER LETTERS (2010)
Combined Delivery and Magnetic Resonance Imaging of Neural Cell Adhesion Molecule-Targeted Doxorubicin-Containing Liposomes in Experimentally Induced Kaposi's Sarcoma
Cristina Grange et al.
CANCER RESEARCH (2010)
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
Robert T. O'Donnell et al.
INVESTIGATIONAL NEW DRUGS (2010)
Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome
Ayele H. Negussie et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy
Pallab Pradhan et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein
Tao Wang et al.
NANOMEDICINE (2010)
Reduction-Sensitive, Robust Vesicles with a Non-covalently Modifiable Surface as a Multifunctional Drug-Delivery Platform
Kyeng Min Park et al.
SMALL (2010)
Annexin A5-Functionalized Liposomes for Targeting Phosphatidylserine-Exposing Membranes
Boris Garnier et al.
BIOCONJUGATE CHEMISTRY (2009)
Disaccharide-modified liposomes and their in vitro intracellular uptake
Chung Kil Song et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Targeted delivery of doxorubicin using stealth liposomes modified with transferrin
XueMing Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Liposome drugs' loading efficiency: A working model based on loading conditions and drug's physicochemical properties
Daniel Zucker et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Lipoplexes Targeting the CD44 Hyaluronic Acid Receptor for Efficient Transfection of Breast Cancer Cells
Claudio Surace et al.
MOLECULAR PHARMACEUTICS (2009)
Targeted delivery of doxorubicin via estrone-appended liposomes
Shivani Rai et al.
JOURNAL OF DRUG TARGETING (2008)
Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments
Arnaud Beduneau et al.
BIOMATERIALS (2007)
Antitumor activity of an epithelial cell adhesion molecule-targeted nanovesicular drug delivery system
Sajid Hussain et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice
Bhawna Gupta et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells
Tomotaka Kobayashi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
The cardiotoxicology of anthracycline chemotherapeutics: Translating molecular mechanism into preventative medicine
XY Peng et al.
MOLECULAR INTERVENTIONS (2005)
Anchorage of synthetic peptides onto liposomes via hydrazone and α-oxo hydrazone bonds.: Preliminary functional investigations
L Bourel-Bonnet et al.
BIOCONJUGATE CHEMISTRY (2005)
Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer
Y Matsumura et al.
ANNALS OF ONCOLOGY (2004)
Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo
H Hatakeyama et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors:: an open-label, single-dose study
K Mross et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Anisamide-targeted stealth liposomes: A potent carrier for targeting doxorubicin to human prostate cancer cells
R Banerjee et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome
N Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Chemical characterization of α-oxohydrazone ligation on colloids:: toward grafting molecular addresses onto biological vectors
P Chenevier et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner
S Hosokawa et al.
BRITISH JOURNAL OF CANCER (2003)
Controlled targeting of liposomal doxorubicin via the folate receptor in vitro
JM Saul et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating
TS Levchenko et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
A growth factor antagonist as a targeting agent for sterically stabilized liposomes in human small cell lung cancer
JN Moreira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors
VP Torchilin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
p-nitrophenylcarbonyl-PEG-PE-liposomes:: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups
VP Torchilin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer
EH Moase et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
Specific binding of sterically stabilized anti-B-cell immunoliposomes and cytotoxicity of entrapped doxorubicin
BB Lundberg et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
Differential reactivity of maleimide and bromoacetyl functions with thiols: Application to the preparation of liposomal diepitope constructs
P Schelte et al.
BIOCONJUGATE CHEMISTRY (2000)
分享论文
